Clinical Trial Update: TAPS2 Transfusion Antenatally in Pregnant Women With SCD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating antenatal transfusion in pregnant women with sickle cell disease (SCD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Transfusion Complication
• Pregnancy High Risk
• Sickle Cell Disease

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Sickle Cell Disease, Pregnancy, High Risk | Phase 2 | Status: UNKNOWN